Thursday, May 24, 2018

google plus

Posted at: Apr 21, 2017, 2:38 PM; last updated: Apr 21, 2017, 2:38 PM (IST)

Narayana Hrudayalaya to acquire Panacea arm for Rs 180 crore

New Delhi, April 21

Narayana Hrudayalaya has entered into an agreement with Panacea Biotec to fully acquire its subsidiary NewRise Healthcare for an enterprise value of Rs 180 crore.

The company has “entered into a definitive agreement to acquire 100 per cent stake in NewRise Healthcare Pvt Ltd from Panacea Biotec Ltd to announce its first hospital in Gurugram,” Narayana Hrudayalaya said in a BSE filing on Friday.

NewRise Healthcare has set up a multi-specialty hospital in Gurugram which is in final stages of completion and is expected to be commissioned in the next nine months.

This transaction is intended to consolidate Narayana Hrudayalaya’s footprint in the northern cluster.

“This development is a step forward in the direction towards reinforcing the newly formed Northern cluster. It also echoes our group’s commitment towards developing this region as vibrant as the existing Karnataka and Eastern clusters,” Narayana Hrudayalaya Vice Chairman, MD and Group CEO Ashutosh Raghuvanshi said.

The group believes its recent ventures in NCR will help it target this key region more efficiently while accelerating trajectory to become a true pan-India health care service provider, he added.

Founded in 2000 by Devi Prasad Shetty, Narayana Hrudayalaya has a network of 23 hospitals and seven heart centres across India and a single hospital overseas at Cayman Islands with over 5,700 operational beds across all its centres.

Shares of Narayana Hrudayalaya were trading 0.39 per cent lower at Rs 317.10 per scrip while Panacea Biotec’s stock was trading 3.58 per cent higher at Rs 164.80 apiece on BSE on Friday. PTI


All readers are invited to post comments responsibly. Any messages with foul language or inciting hatred will be deleted. Comments with all capital letters will also be deleted. Readers are encouraged to flag the comments they feel are inappropriate.
The views expressed in the Comments section are of the individuals writing the post. The Tribune does not endorse or support the views in these posts in any manner.
Share On